María de la Fuente

María de la Fuente, co-founder and CEO/CSO of DIVERSA, has a Ph.D. in pharmaceutical technology, nanotechnology, and drug administration from the University of Santiago de Compostela. In addition, she has training in management, direction, and entrepreneurship, highlighting his participation in the Senior Management Program of Research, Innovation and Technology Transfer Institutions of the University of Navarra (IESE), the program in Business Leadership Development and Team Management from ESADE (Ramon Llull University), and the Caixaimpulse program, taught by the Barcelona School of Management, for knowledge transfer and entrepreneurship. She has completed an Executive MBA (Galicia Business School). She has also participated in Bootcamps such as Oncostars and PANACEA in Oxford and received additional training in programs from the Xunta de Galicia (GAIN -Oxentia- and ACIS), as well as other Europeans (EIT Health). Her previous activity in technology transfer is related to the license to Advancell SL of several patents, being co-inventor of them, and to the participation in knowledge transfer during her stay in the SOP-UCL. Concerning her professional experience, María is the head of the Nano-Oncology and Translational Therapeutics group at the Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, and has experience in leadership, teamwork, and resource management. From her professional independence as Principal Investigator, she has raised more than 4.5M€ of public and private funds in competitive calls, of which 0.6M€ have been specific for technology transfer.